Tonsil stones (tonsilloliths): causes, management, and when to see a specialist

Tonsil stones (tonsilloliths) are calcified concretions that form inside the natural pockets — called crypts — of the palatine tonsils. They are one of the most common causes of persistent bad breath (halitosis) and a chronic tickling or foreign-body sensation at the back of the throat. They are almost always benign. This article explains what causes them, how to manage them, and the small number of situations where further assessment is essential.

A. What are tonsil stones and who gets them?

Tonsil stones form when food debris, dead epithelial cells, mucus, and bacteria accumulate inside deep tonsillar crypts and gradually calcify (Babu et al., 2019). The calcification is driven by calcium phosphate precipitation in the alkaline microenvironment created by bacterial metabolism within the crypt. The bacteria involved are predominantly anaerobic Gram-negative organisms — Fusobacterium nucleatum, Prevotella, and Solobacterium moorei — that metabolise sulphur-containing amino acids from food and dead cells, releasing the volatile sulphur compounds (hydrogen sulphide, methyl mercaptan) responsible for halitosis (Babu et al., 2019).

On routine examination, tonsil stones are found in approximately 10% of adults, and up to 30–50% of people with chronic tonsillitis. Most are asymptomatic and discovered incidentally on a dental panoramic X-ray or throat examination. When symptomatic, the dominant complaint is halitosis — often noticed first by a partner, close friend, or colleague — followed by a mild scratching or foreign-body sensation, intermittent referred ear pain via the glossopharyngeal nerve, and, in some people, a chronic soft cough from tonsillar irritation.

Risk factors for developing symptomatic tonsil stones include anatomically deep or scarred tonsillar crypts (often following glandular fever or repeated tonsillitis episodes), chronic mouth breathing from a blocked nose or obstructive sleep apnoea, post-nasal drip from chronic rhinosinusitis, gastro-oesophageal reflux, poor dental hygiene, dehydration, and smoking. None of these are prerequisites — people with no identifiable risk factor commonly develop tonsil stones.

B. How are tonsil stones diagnosed and managed?

Diagnosis is clinical. Your GP will ask you to say “ahh” and may use a tongue blade to gently depress the tonsil. Visible yellow-white concretions in the crypts confirm the diagnosis. No imaging is required for straightforward cases. A patient who describes spontaneously expelling small white lumps with a cheesy smell is describing a pathognomonic experience.

First-line management is conservative. The great majority of people — roughly 90% — respond adequately to the following measures (RACGP):

• Saltwater gargles four to six times daily (half a teaspoon of salt dissolved in a glass of warm water, gargled at the back of the throat for 30 seconds) flush debris from the crypts and reduce the bacterial load.
• Tongue scraping daily, from back to front, reduces the layer of tongue coating that is itself the largest single source of intra-oral halitosis (Outhouse et al., Cochrane 2006).
• Dental review and oral hygiene should not be overlooked — periodontal disease contributes substantially to halitosis independent of tonsil stones, and a dental hygienist can address plaque and gingival disease more effectively than mouthwash alone.
• A low-pressure oral irrigator (set to the lowest setting) directed at the tonsillar surface can mechanically loosen stones. High pressure must be avoided as it risks crypt trauma and bleeding.
• Cautious self-removal — a clean cotton bud or fingertip pressed gently alongside a visible stone can dislodge it. This is suitable for cooperative adults only; it is not appropriate for children, people on anticoagulant therapy, those with a strong gag reflex, or anyone where the tonsil appears asymmetric or unusual.
• Cetylpyridinium chloride mouthwash (available over the counter) used twice daily reduces volatile sulphur compound levels and is suitable for long-term use without the staining or dysgeusia that accompany prolonged chlorhexidine use (AMH).
• Chlorhexidine 0.2% mouthwash is effective for short courses (up to 14 days) but causes tooth staining and taste disturbance with longer use.

Antibiotics are not indicated for tonsil stones. The stones themselves are not an infection. Prescribing antibiotics in the absence of active bacterial tonsillitis is contrary to eTG guidance and promotes antibiotic resistance without benefit to the patient. If a concurrent acute streptococcal tonsillitis is present, your GP will follow eTG criteria for that episode.

Addressing contributing factors often substantially reduces recurrence. A blocked nose causing mouth breathing should be investigated (allergic rhinitis, septal deviation). Reflux-driven halitosis and throat irritation responds to a trial of a proton pump inhibitor. Adequate hydration and smoking cessation both reduce biofilm formation.

C. Controversies and emerging options

The main area of debate involves the threshold for surgical referral when tonsil stones are the dominant problem but the standard criteria for tonsillectomy are not met.

Paradise criteria for tonsillectomy are the validated surgical threshold (Paradise et al., 1984; SIGN 117; RANZCOOHNS 2024): seven or more distinct episodes of acute tonsillitis in one year, five or more per year over two consecutive years, or three or more per year over three years. The Cochrane evidence (Burton et al., 2014) confirms that tonsillectomy in children meeting these criteria reduces throat infection episodes by approximately three per year over the following two years. Benefit in adults meeting the same threshold is real but less pronounced. Tonsillectomy carries a post-operative haemorrhage risk of 1–5%, predominantly in the 5–10 days after surgery, and recovery involves significant throat pain for 7–10 days.

Laser or coblation cryptolysis is an in-office procedure (performed under local anaesthesia) that ablates the walls of the tonsillar crypts without removing the tonsil altogether. It ablates the crypt walls that trap debris while preserving tonsillar tissue. This is a reasonable option for people with persistent symptomatic tonsilloliths who decline tonsillectomy or do not meet Paradise criteria. Access in Australia is limited to selected ENT practices and the evidence base — while encouraging in case series — lacks robust randomised controlled trial support.

Probiotic Streptococcus salivarius K12 and M18 lozenges have been studied as adjuncts. Small randomised trials including Australian research (Burton et al., 2013) demonstrate reduction in volatile sulphur compounds and a degree of competitive inhibition of pathogenic streptococcal colonisation. Evidence quality is moderate and commercial bias is a concern; the intervention is reasonable as a safe adjunct but not a standalone treatment.

D. Australian operations — MBS, PBS, and referral pathways

General practice consultations are rebatable under MBS items 23, 36, and 44 for standard, long, and prolonged consultations. Complex care planning, if relevant for multimorbidity, is supported by GPCCMP items 965 and 967. Aboriginal and Torres Strait Islander patients may access a comprehensive health check under item 715.

ENT specialist consultations attract MBS items 104 and 105. Flexible nasendoscopy is item 41819. Tonsillectomy when performed by a specialist is item 41789. CT neck with contrast for suspected deep neck space infection or tonsillar mass is item 56235.

PBS medications relevant to this presentation:

• Phenoxymethylpenicillin (penicillin V) — General Schedule for acute streptococcal tonsillitis per eTG.
• Benzydamine spray and mouthwash — General Schedule for symptomatic pharyngeal discomfort.
• PPIs (omeprazole, pantoprazole, esomeprazole) — General Schedule for concurrent gastro-oesophageal reflux.
• Paracetamol and ibuprofen — General Schedule and over the counter.
• Cetylpyridinium and chlorhexidine mouthwashes — available over the counter, not PBS-listed.

Telehealth (MBS items 91790 and 91891) is appropriate for established-patient follow-up after an initial in-person oropharyngeal examination has been documented. It is not suitable for the initial assessment of suspected tonsillar malignancy.

Mental Health Care Plans (items 2715 and 2717) may be applicable for patients with halitophobia (a persistent false belief about halitosis that is causing significant social withdrawal or anxiety) where psychological intervention is warranted.

Head and neck cancer pathway: Australia’s Cancer Council Optimal Care Pathway for Head and Neck Cancers (Cancer Council Australia) specifies urgent ENT referral (target within two weeks) for suspected tonsillar malignancy. GPs are responsible for acting on unilateral tonsillar asymmetry rather than attributing it to tonsil stones without exclusion.

E. Special populations

Children: Tonsil stones are uncommon in young children and become more prevalent in adolescence. Self-removal is not appropriate in children. If recurrent acute tonsillitis is driving symptoms, the Paradise criteria apply. In Aboriginal and Torres Strait Islander children living in remote communities, undiagnosed Group A streptococcal pharyngitis carries risk of acute rheumatic fever — this is a distinct priority from tonsillolithiasis and must not be missed or attributed to tonsil stones without a throat swab.

Older adults: The malignancy differential carries greater weight with increasing age, smoking history, and alcohol use. Persistent unilateral tonsillar enlargement in a patient aged over 40 with these risk factors warrants an urgent ENT referral, not watchful waiting.

People with immunocompromise (HIV, solid organ transplant recipients, patients on chemotherapy): tonsillar ulceration or unusual tonsillar lesions may represent lymphoma, primary HIV, syphilis, or atypical infection. Standard conservative management for tonsil stones is not appropriate without first ruling out these possibilities.

People who are pregnant: Gargles and tongue scraping are safe throughout pregnancy. Most OTC mouthwashes are acceptable at standard doses; check with a pharmacist or GP regarding any prolonged use. Tonsillectomy in pregnancy is deferred where possible to the post-partum period. Refer to an ENT specialist promptly if red-flag features are present — malignancy does not wait.

When to escalate

Return to your GP urgently if you notice any of the following:

• One tonsil visibly larger than the other for more than two weeks
• Persistent earache on one side without ear infection
• A new lump in the neck that does not settle within two weeks
• Unexplained weight loss, difficulty swallowing your own saliva, or voice change
• Severe unilateral throat pain with difficulty opening the mouth wide, drooling, or fever — these suggest a peritonsillar abscess (quinsy) requiring same-day assessment or emergency department attendance

These symptoms are not caused by tonsil stones and require active assessment to exclude serious pathology including head and neck cancer. Early identification significantly improves outcomes (Cancer Council Australia OCP).

What this article is and is not

This article provides guideline-aligned educational information about tonsil stones for an Australian audience. It is not a substitute for a clinical assessment by your own GP or ENT specialist, who will take into account your full history, examination findings, and individual circumstances. Specific symptoms — particularly unilateral tonsillar asymmetry, neck lumps, unexplained weight loss, or difficulty swallowing — require prompt in-person assessment and cannot be managed on the basis of reading an article. Nothing here constitutes a diagnosis, treatment plan, or specialist advice.

---

Sources cited

1. Babu BB et al. — Tonsilloliths: a review. Indian J Otolaryngol Head Neck Surg 2019
2. Burton MJ et al. — Cochrane: Tonsillectomy for chronic/recurrent acute tonsillitis 2014
3. Paradise JL et al. — Tonsillectomy for recurrent throat infections. NEJM 1984
4. SIGN 117 — Management of sore throat and indications for tonsillectomy
5. ASOHNS / RANZCOOHNS 2024 position statement on tonsillectomy
6. Outhouse TL et al. — Cochrane: Tongue scraping for halitosis 2006
7. Burton JP et al. — S. salivarius M18 probiotic. J Med Microbiol 2013
8. Therapeutic Guidelines (eTG complete) — Pharyngitis and tonsillitis
9. RACGP — Halitosis and chronic tonsillitis (Australian Family Physician)
10. AMH — Australian Medicines Handbook
11. Cancer Council Australia — Optimal Care Pathway for Head and Neck Cancer
12. HealthDirect — Tonsillitis
13. Better Health Channel — Tonsillitis